| abstract |
A crystal polymorph of a factor Xa inhibitor and compositions and methods thereof are provided. Crystalline forms of betrixaban maleate, compositions thereof and methods of preparation or use are provided herein. In another aspect, a subject comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of one or more polymorphs of betrixaban maleate provided herein. Pharmaceutical compositions for preventing or treating conditions characterized by undesirable thrombosis in are provided. In other embodiments, the pharmaceutical composition is suitable for oral delivery. [Selection figure] None |